The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*
The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
Over the last decade, the concept of an IGFBP family has been well accepted, based on structural similarities and on functional abilities to bind IGFs with high affinities. The existence of other potential IGFBPs was left open. The discovery of proteins with N-terminal domains bearing striking structural similarities to the N terminus of the IGFBPs, and with reduced, but demonstrable, affinity for IGFs, raised the question of whether these proteins were "new" IGFBPs (22, 23, 217). The N-terminal domain had been uniquely associated with the IGFBPs and has long been considered to be critical for IGF binding. No other function has been confirmed for this domain to date. Thus, the presence of this important IGFBP domain in the N terminus of other proteins must be considered significant. Although these other proteins appear capable of binding IGF, their relatively low affinity and the fact that their major biological actions are likely to not directly involve the IGF peptides suggest that they probably should not be classified within the IGFBP family as provisionally proposed (22, 23). The conservation of this single domain, so critical to high-affinity binding of IGF by the six IGFBPs, in all of the IGFBP-rPs, as well, speaks to its biological importance. Historically, and perhaps, functionally, this has led to the designation of an "IGFBP superfamily". The classification and nomenclature for the IGFBP superfamily, are, of course, arbitrary; what is ultimately relevant is the underlying biology, much of which still remains to be deciphered. The nomenclature for the IGFBP related proteins was derived from a consensus of researchers working in the IGFBP field (52). Obviously, a more general consensus on nomenclature, involving all groups working on each IGFBP-rP, has yet to be reached. Further understanding of the biological functions of each protein should help resolve the nomenclature dilemma. For the present, redesignating these proteins IGFBP-rPs simplifies the multiple names already associated with each IGFBP related protein, and reinforces the concept of a relationship with the IGFBPs. Beyond the N-terminal domain, there is a lack of structural similarity between the IGFBP-rPs and IGFBPs. The C-terminal domains do share similarities to other internal domains found in numerous other proteins. For example, the similarity of the IGFBP C terminus to the thyroglobulin type-I domain shows that the IGFBPs are also structurally related to numerous other proteins carrying the same domain (87). Interestingly, the functions of the different C-terminal domains in members of the IGFBP superfamily include interactions with the cell surface or ECM, suggesting that, even if they share little sequence similarities, the C-terminal domains may be functionally related. The evolutionary conservation of the N-terminal domain and functional studies support the notion that IGFBPs and IGFBP-rPs together form an IGFBP superfamily. A superfamily delineates between closely related (classified as a family) and distantly related proteins. The IGFBP superfamily is therefore composed of distantly related families. The modular nature of the constituents of the IGFBP superfamily, particularly their preservation of an highly conserved N-terminal domain, seems best explained by the process of exon shuffling of an ancestral gene encoding this domain. Over the course of evolution, some members evolved into high-affinity IGF binders and others into low-affinity IGF binders, thereby conferring on the IGFBP superfamily the ability to influence cell growth by both IGF-dependent and IGF-independent means (Fig. 10). A final word, from Stephen Jay Gould (218): "But classifications are not passive ordering devices in a world objectively divided into obvious categories. Taxonomies are human decisions imposed upon nature--theories about the causes of nature's order. The chronicle of historical changes in classification provides our finest insight into conceptual revolutions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567
DAUGHADAY, W. H., & ROTWEIN, P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-1-68 · Cited by 1,725
Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., & Binoux, M. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90507-5 · Cited by 1,143
Rajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
STRUCTURE AND FUNCTION OF THE MANNOSE 6-PHOSPHATE/INSULINLIKE GROWTH FACTOR II RECEPTORS
Kornfeld, S. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.001515 · Cited by 1,092
Görlich, D., & Mattaj, I. W. (1996) · Science · doi:10.1126/science.271.5255.1513 · Cited by 1,086
Research works printed but not linked: 56
- Rosenfeld, 1987, Somatomedin action and tissue growth-factor receptors, In: Robbins R, Melmed S (eds) Acromegaly. Plenum Press, New York, pp, 45
- Lowe, 1991, Biological actions of the insulin-like growth factors, In: LeRoith D (ed) Insulin-like Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton, FL, pp, 49
- Oh, 1998, IGF-independent actions of IGFBPs, In: Takano K, Hizuka N, Takahashi S-I (eds) Molecular Mechanisms to Regulate the Activities of Insulin-Like Growth Factors. Elsevier, Amsterdam, pp, 123
- Luthman, 1989, Human insulin-like growth-factor-binding protein: low-molecular-mass form: protein sequence and cDNA cloning., Eur J Biochem, 180, 259, 10.1111/j.1432-1033.1989.tb14641.x · doi:10.1111/j.1432-1033.1989.tb14641.x
- Grundmann, 1988, Cloning of cDNA encoding human placental protein 12 (PP12): Binding protein for IGF-1 and somatomedin., Nucleic Acids Res, 16, 8711, 10.1093/nar/16.17.8711 · doi:10.1093/nar/16.17.8711
- Akaogi, 1994, Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells., Biochem Biophys Res Commun, 198, 1046, 10.1006/bbrc.1994.1149 · doi:10.1006/bbrc.1994.1149
- Schoen, 1995, Cloning and characterization of a chick embryo cDNA and gene fro IGF-binding protein-2., J Mol Endocrinol, 15, 49, 10.1677/jme.0.0150049 · doi:10.1677/jme.0.0150049
- Forbes, 1998, Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain., J Biol Chem, 273, 4647, 10.1074/jbc.273.8.4647 · doi:10.1074/jbc.273.8.4647
- Rodakis, 1983, The B multigene family of chorion proteins in saturniid silkmoths., J Mol Evol, 19, 322, 10.1007/BF02101635 · doi:10.1007/bf02101635
- Jordi, 1989, Nucleotide sequence of the gene coding for the peplomer protein (= spike protein) of infectious bronchitis virus, strain D274., Nucleic Acids Res, 17, 6726, 10.1093/nar/17.16.6726 · doi:10.1093/nar/17.16.6726
- Evans, 1990, A gene from pea (Pisum sativum L.) with homology to metallothion genes., FEBS Lett, 262, 29, 10.1016/0014-5793(90)80145-9 · doi:10.1016/0014-5793(90)80145-9
- Bohn, 1980, New placental protein (PP15) with immunosuppressive properties., Arch Gynecol, 230, 167, 10.1007/BF02108272 · doi:10.1007/bf02108272
- Zapf, 1988, Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors., Biochem Biophys Res Commun, 156, 1187, 10.1016/S0006-291X(88)80758-7 · doi:10.1016/s0006-291x(88)80758-7
- Conover, 1993, Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells., J Clin Endocrinol Metab, 76, 1153
- Bach, 1993, Rat PC12 pheochromocytoma cells synthesize insulin-like growth factor-binding protein-6., Endocrinology, 133, 990, 10.1210/endo.133.3.7689963 · doi:10.1210/endo.133.3.7689963
- Hoeck, 1994, Identification of the major sites of phosphorylation in IGF binding protein-3., J Cell Biochem, 56, 262, 10.1002/jcb.240560220 · DOI
- Coverley, 1995, Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I., Endocrinology, 136, 5778, 10.1210/endo.136.12.7588336 · doi:10.1210/endo.136.12.7588336
- Morabito, 1995, Molecular cloning of bullfrog saxiphilin: a unique relative of the transferrin family that binds saxitoxin. (Correction)., Proc Natl Acad Sci USA, 92, 6651, 10.1073/pnas.92.14.6651 · doi:10.1073/pnas.92.14.6651
- Booth, 1996, Structure-function relationships in the heparin-binding c-terminal region of insulin-like growth factor binding protein-3., Growth Regul, 6, 206
- Smith, 1994, Insulin-like growh factor-binding protein-3 (IGFBP-3) concentration in rat Sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans., Endocrinology, 135, 359, 10.1210/endo.135.1.7516869 · doi:10.1210/endo.135.1.7516869
- Cohen, 1992, Prostate specific antigen is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma., J Clin Endocrinol Metab, 75, 1046
- Fielder, 1994, Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3., Growth Regul, 1, 164
- Lalou, 1997, Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity., C R Acad Sci III, 320, 621, 10.1016/S0764-4469(97)85695-8 · doi:10.1016/s0764-4469(97)85695-8
- Vorwerk, 1998, Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine., J Clin Endocrinol Metab, 83, 1392, 10.1210/jcem.83.4.4858 · doi:10.1210/jcem.83.4.4858
- Cheung, 1994, Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line., Endocrinology, 135, 1328, 10.1210/endo.135.4.7523095 · doi:10.1210/endo.135.4.7523095
- Chernausek, 1995, Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4): localization of cleavage sit to non-homologous region of native IGFBP-4., J Biol Chem, 270, 11377, 10.1074/jbc.270.19.11377 · doi:10.1074/jbc.270.19.11377
- Spencer, 1995, A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3., Prog Growth Factor Res, 6, 209, 10.1016/0955-2235(96)00008-7 · doi:10.1016/0955-2235(96)00008-7
- Baxter, 1995, Modulations of human IGF binding protein-3 activity by structural modification., Prog Growth Factor Res, 6, 215, 10.1016/0955-2235(95)00004-6 · doi:10.1016/0955-2235(95)00004-6
- Qin, 1998, Structure-function analysis of the human insulin-like growth factor binding protein-4., J Biol Chem, 273, 23509, 10.1074/jbc.273.36.23509 · doi:10.1074/jbc.273.36.23509
- Hobba, 1996, The insulin-like growth factor (IGF) binding site of bovine insulin-like growth factor binding protein-2 (bIGFBP-2) probed by iodination., J Biol Chem, 271, 30529, 10.1074/jbc.271.48.30529 · doi:10.1074/jbc.271.48.30529
- Hobba, 1998, Alanine screening mutagenesis established tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding., J Biol Chem, 273, 19691, 10.1074/jbc.273.31.19691 · DOI
- Brinkman, 1991, Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity., Mol Endocrinol, 5, 987, 10.1210/mend-5-7-987 · doi:10.1210/mend-5-7-987
- Bramani, 1999, Amino acids within the extracellular matrix (ECM) binding region (201–218) of rat insulin-like growth factor binding protein (IGFBP-5) are important determinants in binding IGF-I., J Mol Endocrinol, 23, 117, 10.1677/jme.0.0230117 · doi:10.1677/jme.0.0230117
- Ho, 1997, Characterization of truncated insulin-like growth factor-binding protein-2 in human milk., Endocrinology, 138, 3811, 10.1210/endo.138.9.5415 · doi:10.1210/endo.138.9.5415
- Wang, 1988, Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors., Biochem Biophys Res Commun, 157, 718, 10.1016/S0006-291X(88)80309-7 · doi:10.1016/s0006-291x(88)80309-7
- Yamanaka, 1999, Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells., Endocrinology, 140, 1319, 10.1210/endo.140.3.6566 · doi:10.1210/endo.140.3.6566
- Fowlkes, 1996, Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor-binding protein-3., J Biol Chem, 271, 14676, 10.1074/jbc.271.25.14676 · doi:10.1074/jbc.271.25.14676
- Rees, 1998, Inhibition of IGFBP-5 binding to extracellular matric and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5., J Cell Biochem, 71, 375, 10.1002/(SICI)1097-4644(19981201)71:3<375::AID-JCB6>3.0.CO;2-M · doi:10.1002/(sici)1097-4644(19981201)71:3<375::aid-jcb6>3.0.co;2-m
- Radulescu, 1994, Nuclear localization signal in insulin-like growth factor-binding protein type 3., Trends Biochem Sci, 19, 278, 10.1016/0968-0004(94)90004-3 · doi:10.1016/0968-0004(94)90004-3
- Andress, 1998, Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor, Am J Physiol, 274, E744
- Damon, 1997, Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis., Exp Cell Res, 237, 192, 10.1006/excr.1997.3787 · doi:10.1006/excr.1997.3787
- Pereira, 1999, Parathyroid hormone increases mac25/insulin-like growth factor-binding protein-related protein-1 expression in cultured osteoblasts., Endocrinology, 140, 1998, 10.1210/endo.140.5.6692 · doi:10.1210/endo.140.5.6692
- Inoguchi, 1986, Reducted serum-stimulatory activity on prostacyclin production by cultured aortic endothelial cells in diabetes mellitus., Haemostasis, 16, 447
- Inoguchi, 1989, Abnormality in porstacyclin-stimulatory activity in sera from diabetes., Metabolism, 38, 837, 10.1016/0026-0495(89)90229-1 · doi:10.1016/0026-0495(89)90229-1
- Groot, 1985, The role of thrombin in the regulation of the endothelial prostaglandin production., Biochim Biophys Acta, 846, 342, 10.1016/0167-4889(85)90004-7 · doi:10.1016/0167-4889(85)90004-7
- Rosenfeld, 1998, Editorial: The blind men and the elephant - a parable for the study of insulin-like growth factor binding proteins., Endocrinology, 139, 5, 10.1210/endo.139.1.5746 · doi:10.1210/endo.139.1.5746
- Masakado, 1995, Immunohistochemical localization of a novel peptide, prostacyclin-stimulating factor (PSF), in human tissues., Thromb Haemost, 74, 1407, 10.1055/s-0038-1649955 · doi:10.1055/s-0038-1649955
- Umeda, 1996, Prostacyclin-stimulating factor, novel protein, and diabetic angiopathy, Diabetes, 45, S111, 10.2337/diab.45.3.S111 · doi:10.2337/diab.45.3.s111
- Haustein, 1998, Pathophysiology of scleroderma: an update., J Eur Acad Dermatol Vernereol, 11, 1, 10.1111/j.1468-3083.1998.tb00945.x · doi:10.1111/j.1468-3083.1998.tb00945.x
- Martin, 1994, Regulation and actions of the insulin-like growth factor binding proteins, In: Kohler PO (ed) Current Opinion in Endocrinology and Diabetes. Current Science, Philadelphia, pp, 16
- Martinerie, 1996, Regulation of nov by WT1: a potential role for nov in nephrogenesis., Oncogene, 12, 1479
- Hainsworth, 1992, Rearrangement of chromosone 1p in breast cancer correlates with poor prognostic features., Br J Cancer, 66, 131, 10.1038/bjc.1992.229 · doi:10.1038/bjc.1992.229
- Gehring, 1995, The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma., Cancer Res, 55, 5366
- Mizushima, 1996, Isolation and characterization of the human chromosomal gene for prostacyclin-stimulating factor., J Biochem, 120, 929, 10.1093/oxfordjournals.jbchem.a021508 · doi:10.1093/oxfordjournals.jbchem.a021508
- Collet, 1998, How many insulin-like growth factor binding proteins?, Mol Cell Endocrinol, 139, 1, 10.1016/S0303-7207(98)00078-1 · doi:10.1016/s0303-7207(98)00078-1
- Zazzi, 1998, Structure and transcription regulation of the human insulin-like growth factor binding protein 4 gene (IGFBP4)., Genomics, 49, 401, 10.1006/geno.1998.5283 · doi:10.1006/geno.1998.5283
Cited by
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,750
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Colao, A., Ferone, D., Marzullo, P., & Lombardi, G. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0022 · Cited by 1,309
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)
Lu, Y., Zi, X., Zhao, Y., Mascarenhas, D., & Pollak, M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.24.1852 · Cited by 882
The many faces of insulin-like peptide signalling in the brain
Fernandez, A. M., & Torres-Alemán, I. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3209 · Cited by 872
Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton
Canalis, E., Economides, A. N., & Gazzerro, E. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0023 · Cited by 863
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Khandwala, H. M., McCutcheon, I. E., Flyvbjerg, A., & Friend, K. E. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0399 · Cited by 843
Baxter, R. C. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.6.e967 · Cited by 672
Insulin-like growth factor signaling in fish
Wood, A. W., Duan, C., & Bern, H. A. (2005) · International Review of Cytology · doi:10.1016/s0074-7696(05)43004-1 · Cited by 657
Insulin-like growth factor 1 (IGF-1): a growth hormone
Laron, Z. (2001) · Molecular Pathology · doi:10.1136/mp.54.5.311 · Cited by 608
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Nakae, J., Kido, Y., & Accili, D. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0452 · Cited by 554
The Human Histone Deacetylase Family
Gray, S. G., & Ekström, T. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5080 · Cited by 546
Lefranc, F., Brotchi, J., & Kiss, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.089 · Cited by 526
IGF binding proteins in cancer: mechanistic and clinical insights
Baxter, R. C. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3720 · Cited by 525
IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
Allard, J. B., & Duan, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00117 · Cited by 515
Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach
Grønborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O. N., Hruban, R. H., Goggins, M. G., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500178-mcp200 · Cited by 482
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
Juul, A. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00038-8 · Cited by 467
IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms
Mohan, S., & Baylink, D. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750019 · Cited by 444
Molecular interactions of the IGF system
Denley, A., Cosgrove, L. J., Booker, G. W., Wallace, J. C., & Forbes, B. E. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.04.004 · Cited by 437
Lymphocyte trafficking across high endothelial venules: dogmas and enigmas
Miyasaka, M., & Tanaka, T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1354 · Cited by 435
The CCN family of proteins: structure–function relationships
Holbourn, K. P., Acharya, K. R., & Perbal, B. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.07.006 · Cited by 419
Dyer, A. H., Vahdatpour, C., Sanfeliu, A., & Tropea, D. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.056 · Cited by 377
Nässel, D. R., & Broeck, J. V. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2063-3 · Cited by 361
Schrijvers, B. F., De Vriese, A. S., & Flyvbjerg, A. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0018 · Cited by 353
Frystyk, J. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.06.001 · Cited by 338
Sarrazin, S., Adam, E., Lyon, M., Depontieu, F., Motte, V., Landolfi, C., Lortat-Jacob, H., Bechard, D., Lassalle, P., & Delehedde, M. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.004 · Cited by 337
Denduluri, S. K., Idowu, O., Wang, Z., Liao, Z., Yan, Z., Mohammed, M. K., Ye, J., Wei, Q., Wang, J., Zhao, L., et al. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.10.004 · Cited by 331
Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
Jogie-Brahim, S., Feldman, D., & Oh, Y. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0028 · Cited by 323
Self-citationDunn, G. A., & Bale, T. L. (2009) · Endocrinology · doi:10.1210/en.2009-0500 · Cited by 317
The IGF system and breast cancer.
Sachdev, D., & Yee, D. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080197 · Cited by 314
van den Boom, J., Wolter, M., Kuick, R., Misek, D. E., Youkilis, A. S., Wechsler, D. S., Sommer, C., Reifenberger, G., & Hanash, S. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63463-3 · Cited by 307
Laursen, L. S., Overgaard, M. T., Søe, R., Boldt, H. B., Sottrup-Jensen, L., Giudice, L. C., Conover, C. A., & Oxvig, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02760-0 · Cited by 289
Insulin-Like Growth Factor (IGF) System in Liver Diseases
Adamek, A., & Kasprzak, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051308 · Cited by 284
“In addition, IGFBPs’ activity is also regulated by IGFBP proteases [14,19,24,25].”
BackgroundWheatcroft, S. B., & Kearney, M. T. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.01.002 · Cited by 278
Nieto-Estévez, V., Defterali, Ç., & Vicario-Abejón, C. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00052 · Cited by 274
Overgaard, M. T., Boldt, H. B., Laursen, L. S., Sottrup-Jensen, L., Conover, C. A., & Oxvig, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102191200 · Cited by 267
Smith, T. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002469 · Cited by 267
Rajpathak, S. N., Gunter, M. J., Wylie‐Rosett, J., Ho, G. Y. F., Kaplan, R. C., Muzumdar, R., Rohan, T. E., & Strickler, H. D. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.919 · Cited by 265
Hormonal Regulation of Fetal Growth
Gicquel, C., & Le Bouc, Y. (2006) · Hormone Research in Paediatrics · doi:10.1159/000091503 · Cited by 257
Honegger, B., Galic, M., Köhler, K., Wittwer, F., Brogiolo, W., Hafen, E., & Stocker, H. (2008) · Journal of Biology · doi:10.1186/jbiol72 · Cited by 254
Insulin-Like Growth Factor-1 as a Vascular Protective Factor
Conti, E., Carrozza, C., Capoluongo, E., Volpe, M., Crea, F., Zuppi, C., & Andreotti, F. (2004) · Circulation · doi:10.1161/01.cir.0000144309.87183.fb · Cited by 253
Interorgan Communication Pathways in Physiology: Focus on Drosophila
Droujinine, I. A., & Perrimon, N. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-121415-122024 · Cited by 215
Singh, P., Alex, J. M., & Bast, F. (2014) · Medical Oncology · doi:10.1007/s12032-013-0805-3 · Cited by 203
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors
Evdokimova, V., Tognon, C. E., Benatar, T., Yang, W., Krutikov, K., Pollak, M., Sorensen, P. H. B., & Seth, A. (2012) · Science Signaling · doi:10.1126/scisignal.2003184 · Cited by 176
Lung fibroblasts from patients with emphysema show markers of senescence in vitro
Müller, K.-C., Welker, L., Paasch, K., Feindt, B., Erpenbeck, V., Hohlfeld, J., Krug, N., Nakashima, M., Branscheid, D., Magnussen, H., et al. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-32 · Cited by 173
“Social Life” of Senescent Cells: What Is SASP and Why Study It?
Borodkina, A. V., Deryabin, P. I., Giukova, А. А., & Nikolsky, N. N. (2018) · Acta Naturae · doi:10.32607/20758251-2018-10-1-4-14 · Cited by 170
Insulin-like growth factor (IGF) axis in cancerogenesis
Kasprzak, A., Kwasniewski, W., Adamek, A., & Gozdzicka-Jozefiak, A. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.08.007 · Cited by 130
Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
Jin, L., Shen, F., Weinfeld, M., & Sergi, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00727 · Cited by 123
Byun, H.-O., Lee, Y.-K., Kim, J.-M., & Yoon, G. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.10.122 · Cited by 115
“(IGF) and help to maintain the half-life of circulating IGFs in many tissues, thereby modulating IGF signaling depending on the tissue context (86, 87).”
BackgroundThe Insulin-Like Growth Factor System in Bone
Kawai, M., & Rosen, C. J. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.013 · Cited by 106
Hinrichs, A., Kessler, B., Kurome, M., Blutke, A., Kemter, E., Bernau, M., Scholz, A. M., Rathkolb, B., Renner, S., Bultmann, S., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.006 · Cited by 96
IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways
Benatar, T., Yang, W., Amemiya, Y., Evdokimova, V., Kahn, H., Holloway, C., & Seth, A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1816-4 · Cited by 89
“inhibit proliferation in breast, lung and prostate cancer cell lines, as well as reduce tumor growth in breast and prostate cancer [18, 51–55].”
BackgroundGandhi, P. U., Gaggin, H. K., Sheftel, A. D., Belcher, A. M., Weiner, R. B., Baggish, A. L., Motiwala, S. R., Liu, P. P., & Januzzi, J. L. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.08.018 · Cited by 72
Phua, W. W. T., Wong, M. X. Y., Liao, Z., & Tan, N. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051425 · Cited by 72
“The increased MMP9 secretion from PPARβ/δ agonist-treated endothelial progenitor cells, promotes the (MMP9)-mediated insulin-like growth factor-binding protein 3 (IGFBP3) proteolysis, and thereby modulates the IGF1 activity [165,167].”
BackgroundThe insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential
Bieghs, L., Johnsen, H. E., Maes, K., Menu, E., Van Valckenborgh, E., Overgaard, M. T., Nyegaard, M., Conover, C. A., Vanderkerken, K., & De Bruyne, E. (2016) · Oncotarget · doi:10.18632/oncotarget.8982 · Cited by 61
“Several reports have also described the IGFindependent effects of IGFBPs [58, 64].”
BackgroundInsulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment
de la Garza, R. G., Morales-Garza, L. A., Martin-Estal, I., & Castilla-Cortazar, I. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2761w · Cited by 55
“In summary, the common functions of IGFBPs are: 1) acting as carrier proteins for circulating IGF-1 and controller of its flow from the vascular space to tissues; 2) increasing IGF-1 half-life and regulating its metabolic clearance [34]; 3) modulating the interaction between IGF-1 and its receptor, and thus indirectly…”
BackgroundMireuta, M., Darnel, A., & Pollak, M. (2010) · Growth Factors · doi:10.3109/08977191003745472 · Cited by 55
“Other IGFBPs are present at lower concentrations (Drop et al. 1992; Baxter 1993; Jones and Clemmons 1995; Hwa et al. 1999; Firth and Baxter 2002).”
BackgroundContois, L. W., Nugent, D. P., Caron, J. M., Cretu, A., Tweedie, E., Akalu, A., Liebes, L., Friesel, R., Rosen, C., Vary, C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.267732 · Cited by 46
Insulin‐like growth factor binding protein‐related protein 1 contributes to hepatic fibrogenesis
Guo, X. H., Liu, L. X., Zhang, H. Y., Zhang, Q. Q., Li, Y., Tian, X. X., & Qiu, Z. H. (2014) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12126 · Cited by 39
Storch, S., Kübler, B., Höning, S., Ackmann, M., Zapf, J., Blum, W., & Braulke, T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03204-5 · Cited by 35
Fitzgerald, G. S., Chuchta, T. G., & McNay, E. C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14160 · Cited by 22
Sacks, D. B. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00046-9 · Cited by 7
Metadata
- Authors
- Hwa, V., Oh, Y., & Rosenfeld, R. G.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1999-12-01
- Volume
- 20
- Issue
- 6
- Pages
- 761-787
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2144678487
- Cited by
- 1,079
- References
- 165
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.